Young Men At High Risk Of Developing Myocarditis After COVID
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A report has shown an association between the development of myocarditis and the receipt of messenger RNA (mRNA) vaccines against Covid-19. Study was conducted for diagnosis of myocarditis in patients who had received at least one dose of the BNT162b2 mRNA vaccine (Pfizer–BioNTech). Researchers abstracted the presentation, clinical course, and outcome from the patient’s electronic health record and performed a Kaplan–Meier analysis of the incidence of myocarditis up to 42 days after the first vaccine dose. The incidence per 100,000 persons who had received at least one dose of vaccine was 2.13 cases and the highest incidence of myocarditis 10.69 cases per 100,000 persons was reported in male patients between the ages of 16 and 29 years. A total of 76% of cases of myocarditis were described as mild and 22% as intermediate; 1 case was associated with cardiogenic shock. Although this study cannot directly compare the incidence of myocarditis after vaccination with the incidence in other studies, it provides a point of reference.

If you find this research insightful, please like, comment and share.

For more details, please read:
P●●●●i P●●●●●n and 3 others like this2 shares